Why the study?
Does early neuraxial analgesia increase the risk of operative delivery in nulliparous women?
Does early neuraxial analgesia increase the risk of operative delivery in nulliparous women?
Early neuraxial analgesia does not increase the risk of operative delivery in nulliparous women and is associated with better neonatal outcomes compared to early parenteral opioids.
Answers are grounded in this paper and cite their sources.
Early neuraxial analgesia can be offered without operative delivery concerns in nulliparas; confirms Level 1 evidence supporting guideline use.
A systematic review, including a meta-analysis, on the timing effects of neuraxial analgesia (NA) on cesarean and instrumental vaginal deliveries in nulliparous women was conducted. Of 20 articles identified, 9 met the inclusion quality criteria (3,320 participants). Cesarean delivery (odds ratio, 1.00; 95% confidence interval, 0.82-1.23) and instrumental vaginal delivery (odds ratio, 1.00; 95% confidence interval, 0.83-1.21) rates were similar in the early NA and control groups. Neonates of women with early NA had a higher umbilical artery pH and received less naloxone. In the early NA group, fewer women were not compliant with assigned treatment and crossed over to the control group. Women receiving early NA for pain relief are not at increased risk of operative delivery, whereas those receiving early parenteral opioid and late epidural analgesia present a higher risk of instrumental vaginal delivery for nonreassuring fetal status, worse indices of neonatal wellness, and a lower quality of maternal analgesia.
No takes yet. Share an insight, caveat, or question.
Marucci et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: